indol-3-yl pyruvic acid has been researched along with Alzheimer Disease in 1 studies
3-(indol-3-yl)pyruvic acid : A 2-oxo monocarboxylic acid that is pyruvic acid substituted by a 1H-indol-3-yl group at position 3. It has been found in Lycopersicon esculentum
Alzheimer Disease: A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koyambo-Konzapa, SJ | 1 |
| Mbesse Kongbonga, GY | 1 |
| R, P | 1 |
| Ramlina Vamhindi, BSD | 1 |
| Nsangou, M | 1 |
| Franklin Benial, AM | 1 |
1 other study available for indol-3-yl pyruvic acid and Alzheimer Disease
| Article | Year |
|---|---|
Spectroscopic, quantum chemical, molecular docking and molecular dynamics investigations of hydroxylic indole-3-pyruvic acid: a potent candidate for nonlinear optical applications and Alzheimer's drug.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Humans; Molecular Docking Simulation; Molecular Dynamics S | 2022 |